Innovations in Biotechnology and Medical Sciences

Primary Amoebic Meningoencephalitis (PAM) Cases in Kerala

Note4Students

From UPSC perspective, the following things are important :

Prelims level: Primary Amoebic Meningoencephalitis (PAM); Naegleria fowleri.

Why in the News?

There have been four cases, including three deaths, of the rare, but fatal brain-eating primary amoebic Meningoencephalitis (PAM) in Kerala in the last two months.

What is Primary Amoebic Meningoencephalitis (PAM)?

  • PAM is a rare brain infection caused by Naegleria fowleri, a free-living amoeba found in warm freshwater and soil worldwide.
    • An amoeba is a type of cell or unicellular organism with the ability to alter its shape, primarily by extending and retracting pseudopods.
    • Higher temperatures of up to 115°F (46°C) are conducive to its growth and it can survive for short periods in warm environments.
  • The amoeba enters the body through the nose, typically during activities like swimming, and travels to the brain, causing severe damage.
  • PAM is also non-communicable.
  • Symptoms: Headache, fever, nausea, vomiting, stiff neck, confusion, seizures, hallucinations, and coma.
    • According to the US Centers for Disease Control and Prevention (CDC), most people with PAM die within 1 to 18 days after symptoms begin. It usually leads to coma and death after 5 days.

Diagnosis and Treatment:

  • Currently, there are no established effective treatments for PAM.
  • Diagnosis involves PCR tests of cerebrospinal fluid, though detection can be challenging due to the rarity of PAM.
  • Treatment follows CDC guidelines, including miltefosine, Azithromycin, and Amphotericin B, with miltefosine recently procured by the State Health Department from Germany.
    • Medical interventions typically involve a combination of drugs, including amphotericin B, azithromycin, fluconazole, rifampin, miltefosine, and dexamethasone.

Get an IAS/IPS ranker as your 1: 1 personal mentor for UPSC 2024

Attend Now

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

JOIN THE COMMUNITY

Join us across Social Media platforms.

💥Mentorship New Batch Launch
💥Mentorship New Batch Launch